Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May/Jun;14(3):244-252.
doi: 10.1097/ADM.0000000000000570.

Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey

Affiliations

Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey

Rhiannon Bath et al. J Addict Med. 2020 May/Jun.

Abstract

Objectives: To determine whether diagnosed pre-existing health conditions correlate with Kratom demographics and use patterns.

Methods: A cross-sectional, anonymous US national online survey was conducted among 8049 Kratom users in October, 2016 to obtain demographic, health, and Kratom use pattern information.

Results: People who use Kratom to mitigate illicit drug dependence self-reported less pain and better overall health than individuals who used Kratom for acute/chronic pain. Self-reported improvements in pre-existing mental health symptoms (attention deficit and hyperactivity disorder/attention deficit disorder, anxiety, bipolar disorder, post-traumatic stress disorder, and depression) attributed to Kratom use were greater than those related to somatic symptoms (back pain, rheumatoid arthritis, acute pain, chronic pain, fibromyalgia). Demographic variables, including female sex, older age, employment status, and insurance coverage correlated with increased likelihood of Kratom use.

Conclusions: Kratom use may serve as a self-treatment strategy for a diverse population of patients with pre-existing health diagnoses. Healthcare providers need to be engaging with patients to address safety concerns and potential limitations of its use in clinical practice for specific health conditions.

PubMed Disclaimer

Conflict of interest statement

The authors state no conflict of interest.

Figures

FIGURE 1.
FIGURE 1.
(A) Self-reported pain rating by Kratom use condition. (B) Self-reported overall health rating by Kratom use condition. All values in percent of total respondents who used Kratom for this condition, multiple responses allowed (n = 598 for illicit drug dependence, n = 2007 for prescription drug dependence, n = 5348 for acute/chronic pain, n = 5213 for mental/emotional condition).
FIGURE 2.
FIGURE 2.
Percent distribution of Likert scale responses to self-perceived changes in diagnosed health conditions.
FIGURE 3.
FIGURE 3.
(A) Correlation of demographic variables with diagnosed somatic health conditions. (B) Correlation of demographic variables with diagnosed mental health conditions. (C) Correlation of demographic variables with a diagnosed SUD or no medical condition. All correlations used a Pearson chi-square test for nominal or linear-by-linear statistic for ordinal variables at a significance level of P < 0.05.

References

    1. Ahmad K, Aziz Z. Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. J Ethnopharmacol 2012;141:446–450. - PubMed
    1. Anwar M, Law R, Schier J. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers: United States, 2010–2015. MMWR Morb Mortal Wkly Rep 2016;65:748–749. - PubMed
    1. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth.). Addiction 2008;103:1048–1050. - PMC - PubMed
    1. Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician 2007;76:247–254. - PubMed
    1. Galbis-Reig D A case report of Kratom addiction and withdrawal. WMJ 2016;115:49–52 [quiz 53]. - PubMed